TABLE 1.
Antimicrobial agent | MIC (μg/ml)
|
% Susceptible | % Intermediate | % Resistant | ||
---|---|---|---|---|---|---|
50% | 90% | Range | ||||
Gemifloxacin | 0.003 | 0.007 | 0.0005–0.12 | NAb | ||
Trovafloxacin | 0.007 | 0.03 | 0.002–0.25 | 100 | ||
Grepafloxacin | 0.003 | 0.03 | 0.002–0.25 | 98.5 | 1.5 | |
Levofloxacin | 0.007 | 0.003 | 0.002–0.5 | NA | ||
Ofloxacin | 0.03 | 0.03 | 0.002–1 | 97.8 | 2.2 | |
Ciprofloxacin | 0.003 | 0.01 | 0.001–0.25 | 93.5 | 6.5 | |
Norfloxacin | 0.003 | 0.006 | 0.001–4 | NA | ||
Tetracycline | 1.0 | 4.0 | 0.03–64 | 13.5 | 54.2 | 32.3 |
Spectinomycin | 16.0 | 16.0 | 4–32 | 100 | ||
Ceftriaxone | 0.003 | 0.01 | 0.0005–0.12 | 100 | ||
Cefoxitin | 1.0 | 2.0 | 0.03–4 | 94.8 | 5.2 | |
Penicillin | 1.0 | 64.0 | 0.003–256 | 15.0 | 44.8 | 40.2 |
The breakpoints used were those described in NCCLS document M100-S9 (7). The respective concentrations for the susceptible/intermediate/resistant breakpoints were ≤0.25/NA/NA μg/ml for trovafloxacin and ceftriaxone; ≤0.06/0.12 to 0.5/≥1 μg/ml for grepafloxacin and ciprofloxacin, ≤0.25/0.5 to 1/≥2 μg/ml for ofloxacin and tetracycline, ≤32/64/≥128 for spectinomycin, ≤2/4/≥8 μg/ml for cephoxitin, and ≤0.06/0.12 to 1/≥2 μg/ml for penicillin.
NA, the NCCLS breakpoint is not available.